Development of a multivariate model with desirability-based optimization for simultaneous determination of five co-administrated drugs for the management of COVID-19 infection in their dosage forms via validated RP-HPLC method

References

• Kumar, D.; Trivedi, N. Disease-Drug and Drug-Drug Interaction in COVID-19: Risk and Assessment. Biomed. Pharmacother. 2021, 139. 1–17. DOI: 10.1016/j.biopha.2021.111642.
   Web of Science ®Google Scholar
• Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. DOI: 10.1016/S0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727–733.
   PubMed Web of Science ®Google Scholar
• Yang, W.; Cao, Q.; Qin, L.; Wang, X.; Cheng, Z.; Pan, A.; et al. Clinical Characteristics and Imaging Manifestations of the 2019 Novel Coronavirus Disease (COVID-19): A Multi-Center Study in Wenzhou City, Zhejiang, China. J. Infect. 2020, 80, 388–393.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. People at Increased Risk. U.S. Department of Health & Human Services; 2020. https://www.cdc.gov/coronavirus/2019-ncov/ need-extra-precautions/index.html (accessed Dec 11, 2020).
   Google Scholar
• Becker, R. C. Covid-19 Treatment Update: Follow the Scientific Evidence. J. Thromb. Thrombolysis 2020, 50, 43–53. DOI: 10.1007/s11239-020-02120-9.
   PubMed Web of Science ®Google Scholar
• Afsaneh, G. The Hunt for an Effective Treatment for COVID-19|Feature. Pharm J; 2020. https://www.pharmaceutical-journal.com/news-and-analysis/features/thehunt-for-an-effective-treatment-for-covid-19/20207883.article?firstPass=false (accessed Jul 17, 2020).
   Google Scholar
• Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; et al. Clinical course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet 2020, 395, 1054–1062.
   PubMed Web of Science ®Google Scholar
• Borba, M. G. S.; Val, F. F. A.; Sampaio, V. S.; Alexandre, M. A. A.; Melo, G. C.; Brito, M.; Mourão, M. P. G.; Brito-Sousa, J. D.; Baía-da-Silva, D.; Guerra, M. V. F.; et al. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. JAMA Netw. Open 2020, 3, e208857.
   PubMed Web of Science ®Google Scholar
• Olson, G.; Davis, A. M. Diagnosis and Treatment of Adults with Community-Acquired Pneumonia. JAMA 2020, 323, 885–886.
   PubMed Web of Science ®Google Scholar
• Chen, H.; Guo, J.; Wang, C.; Luo, F.; Yu, X.; Zhang, W.; Li, J.; Zhao, D.; Xu, D.; Gong, Q.; et al. Clinical Characteristics and Intrauterine Vertical Transmission Potential of COVID-19 Infection in Nine Pregnant Women: A Retrospective Review of Medical Records. Lancet 2020, 395, 809–815.
   PubMed Web of Science ®Google Scholar
• Zhao, X.-Y. Clinical Characteristics of Patients with 2019 Coronavirus Disease in a Non-Wuhan Area of Hubei Province, China: A Retrospective Study. BMC Infect. Dis. 2020, 20, 311.
   PubMed Web of Science ®Google Scholar
• Zhao, J. P.; Hu, Y.; Du, R. H.; Chen, Z. S.; Jin, Y.; Zhou, M.; Zhang, J.; Qu, J. M.; Cao, B. Expert Consensus on the Use of Corticosteroid in Patients with 2019-nCoV Pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 2020, 43, 183–184. (In Chinese)
   PubMedGoogle Scholar
• Sterne, J. A. C.; Murthy, S.; Diaz, J. V.; Slutsky, A. S.; Villar, J.; Angus, D. C.; Annane, D.; Azevedo, L. C. P.; Berwanger, O.; Cavalcanti, A. B.; et al. Association between Administration of Systemic Corticosteroids and Mortality among Critically Ill Patients with COVID-19: A Meta-Analysis. JAMA 2020, 324, 1330–1341.
   PubMed Web of Science ®Google Scholar
• The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med. 2021, 384, 693–704. DOI: 10.1056/NEJMoa2021436.
   PubMed Web of Science ®Google Scholar
• Rivera-Caravaca, J. M.; Harrison, S. L.; Buckley, B. J. R.; Fazio-Eynullayeva, E.; Underhill, P.; Marín, F.; Lip, G. Y. H. Efficacy and Safety of Direct-Acting Oral Anticoagulants Compared to Vitamin K Antagonists in COVID-19 Outpatients with Cardiometabolic Diseases. Cardiovasc. Diabetol. 2021, 20, 176. DOI: 10.1186/s12933-021-01368-6.
   PubMed Web of Science ®Google Scholar
• Wilcox, C. M.; Cryer, B.; Triadafilopoulos, G. Patterns of Use and Public Perception of Over-the-Counter Pain Relievers: Focus on Nonsteroidal anti-Inflammatory Drugs. J. Rheumatol. 2005, 32, 2218–2224.
   PubMed Web of Science ®Google Scholar
• Bushra, R.; Aslam, N. An Overview of Clinical Pharmacology of Ibuprofen. Oman Med. J. 2010, 25, 155–1661.
   PubMedGoogle Scholar
• Jóźwiak-Bebenista, M.; Nowak, J. Z. Paracetamol: Mechanism of Action, Applications and Safety Concern. Acta Pol. Pharm. 2014, 71, 11–23.
   PubMed Web of Science ®Google Scholar
• Leal, N. S.; Yu, Y.; Chen, Y.; Fedele, G.; Martins, L. M. Paracetamol Is Associated with a Lower Risk of COVID-19 Infection and Decreased ACE2 Protein Expression: A Retrospective Analysis. Covid 2021, 1, 218–229. DOI: 10.3390/covid1010018.
   Google Scholar
• Jitta, S. R.; Salwa Kumar, L.; Gangurde, P. K.; Verma, R. Development and Validation of High-Performance Liquid Chromatography Method for the Quantification of Remdesivir in Intravenous Dosage Form. Assay Drug Dev. Technol. 2021. 19 , 475–483. DOI: 10.1089/adt.2021.074.
   PubMed Web of Science ®Google Scholar
• Al-Ani, I.; Hamad, M.; Al-Shdefat, R.; Mansoor, K.; Gligor, F.; Dayyih, W. A. Development and Validation of a Stability Indicating RP-HPLC Method of Apixaban in Commercial Dosage Form. IJPSR 2021, 12, 241–251. DOI: 10.13040/IJPSR.0975-8232.12(1).241-51.
   Google Scholar
• Ellwanger, J. B.; Wingert, N. R.; Volpato, N. M.; Garcia, C. V.; Schapoval, E. E. S.; Steppe, M. Analytical Quality by Design Approach for a Stability‑Indicating Method to Determine Apixaban and Its Related Impurities. Chromatographia 2020, 83, 65–75. DOI: 10.1007/s10337-019-03815-9.
   Web of Science ®Google Scholar
• Madan, M. R. M. Stress Degradation Studies and Development of Validated Stability Indicating Assay Method by RP-HPLC for Estimation of Apixaban in Presence of Degradation Products as per ICH Guidelines. Int. J. Pharm. Anal. Res. 2017, 6, 363–384.
   Google Scholar
• Ravisankar, P.; Anusha, S.; Latha, K. S. S.; Shaik, A. K. Development and Validation of a Stability-Indicating Reversed Phase HPLC Method for Determination of Moxifloxacin in Bulk and Pharmaceutical Dosage Form. Int. J. Pharm. Sci. Rev. Res. 2019, 54, 33–40.
   Google Scholar
• Ruan, B.; Yang, L. HPLC and TLC Determination of Dexamethasone Acetate Tablets and Its Related Substances. Chin. J. Pharm. Anal. 2007, 27, 412–413.
   Google Scholar
• Nief Rahman, A.; Khalaf Omar, F. HPLC Method for Determination of Paracetamol in Pharmaceutical Formulations and Environmental Water Samples. World J. Pharm. Res. 2018, 7, 1–10.
   Google Scholar
• Ferreira, S.; Bruns, R.; Ferreira, H.; Matos, G.; David, J.; Brandão, G. C.; da Silva, E. G. P.; Portugal, L.; Reis, P.; Souza, A. S.; Santos, W. Box-Behnken Design: An Alternative for the Optimization of Analytical Methods. Anal. Chim. Acta 2007, 597, 179–186. DOI: 10.1016/j.aca.2007.07.011.
   PubMed Web of Science ®Google Scholar
• Vanaja, K.; Shobha Rani, R. H. Design of Experiments: Concept and Applications of Plackett–Burman Design. Clin. Res. Regul. Aff. 2007, 24, 1–23. DOI: 10.1080/10601330701220520.
   Google Scholar
• Ragonese, R.; Macka, M.; Hughes, J.; Petocz, P. The use of the Box–Behnken Experimental Design in the Optimisation and Robustness Testing of a Capillary Electrophoresis Method for the Analysis of Ethambutol Hydrochloride in a Pharmaceutical Formulation. J. Pharm. Biomed. Anal. 2002, 27, 995–1007. DOI: 10.1016/S0731-7085(01)00659-8.
   PubMed Web of Science ®Google Scholar
• Zidan, A. S.; Sammour, O. A.; Hammad, M. A.; Megrab, N. A.; Habib, M. J.; Khan, M. A. Quality by Design: Understanding the Formulation Variables of a Cyclosporine a Self-Nanoemulsified Drug Delivery Systems by Box–Behnken Design and Desirability Function. Int. J. Pharm. 2007, 332, 55–63. DOI: 10.1016/j.ijpharm.2006.09.060.
   PubMed Web of Science ®Google Scholar
• Box, G. E. P.; Behnken, D. W. Some New Three Level Designs for the Study of Quantitative Variables. Technometrics 1960, 2, 455–475. DOI: 10.1080/00401706.1960.10489912.
   Google Scholar
• Govender, S.; Pillay, V.; Chetty, D. J.; Essack, S. Y.; Dangor, C. M.; Govender, T. Optimisation and Characterisation of Bioadhesive Controlled Release Tetracycline Microspheres. Int. J. Pharm. 2005, 306, 24–40. DOI: 10.1016/j.ijpharm.2005.07.026.
   PubMed Web of Science ®Google Scholar
• ICH Guidelines Q2 (R1). Validation of Analytical Procedures: Text and Methodology; 2011.
   Google Scholar
• Khamanga, S. M.; Walker, R. B. The Use of Experimental Design in the Development of an HPLC-ECD Method for the Analysis of Captopril. Talanta 2011, 83, 1037–1049. DOI: 10.1016/j.talanta.2010.11.025.
   PubMed Web of Science ®Google Scholar
• El-Zaher, A. A.; Mahrouse, M. A. Utility of Experimental Design in Pre-Column Derivatization for the Analysis of Tobramycin by HPLC—Fluorescence Detection: Application to Ophthalmic Solution and Human Plasma. Anal. Chem. Insights 2013, 8, 9–20. DOI: 10.4137/ACI.S11612.
   PubMedGoogle Scholar
• Montgomery, D. C. Design and Analysis of Experiments: Hoboken, NJ: John Wiley & Sons; 2017.
   Google Scholar
• Trinh, T. K.; Kang, L.-S. Application of Response Surface Method as an Experimental Design to Optimize Coagulation Tests. Environ. Eng. Res. 2010, 15, 63–70. DOI: 10.4491/eer.2010.15.2.063.
   Google Scholar
• Morshedi, A.; Akbarian, M. Application of Response Surface Methodology: Design of Experiments and Optimization: A Mini Review. Indian J. Fundam. Appl. Life Sci. 2014, 4, 2434–2439.
   Google Scholar
• Hassib, S. T.; Taha, E. A.; Sharf, M. G.; Mostafa, E. A. RP-HPLC-DAD Method Development and Validation for Simultaneous Determination of Lansoprazole, Tinidazole, Amoxicillin and Naproxen in Their Raw Materials and Combined Dosage Form: DOE Approach for Optimization of the Proposed Method. J. AOAC Int. 2022, 105, 675–687. DOI: 10.1093/jaoacint/qsab159.
   PubMed Web of Science ®Google Scholar
• Chaudhari, S. R.; Shirkhedkar, A. A. Design of Experiment Avenue for Development and Validation of RP-HPLC-PDA Method for Determination of Apremilast in Bulk and in In-House Tablet Formulation. J. Anal. Sci. Technol. 2019, 10, 1–10.
   Web of Science ®Google Scholar